TRB3 mediates vascular remodeling by activating the MAPK signaling pathway in hypoxic pulmonary hypertension
Hypoxic pulmonary hypertension (PH) is a refractory pulmonary vascular remodeling disease, and the efficiency of current PH treatment strategies is unsatisfactory. Tribbles homolog 3 (TRB3), a member of the pseudokinase family, is upregulated in diverse types of cellular stresses and functions as ei...
Saved in:
Published in | Respiratory research Vol. 22; no. 1; pp. 312 - 15 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
BioMed Central Ltd
14.12.2021
BioMed Central BMC |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Hypoxic pulmonary hypertension (PH) is a refractory pulmonary vascular remodeling disease, and the efficiency of current PH treatment strategies is unsatisfactory. Tribbles homolog 3 (TRB3), a member of the pseudokinase family, is upregulated in diverse types of cellular stresses and functions as either a pro-proliferative or pro-apoptotic factor depending on the specific microenvironment. The regulatory mechanisms of TRB3 in hypoxic PH are poorly understood.
We performed studies using TRB3-specific silencing and overexpressing lentiviral vectors to investigate the potential roles of TRB3 on hypoxic pulmonary artery smooth muscle cells (PASMCs). Adeno-associated virus type 1(AVV1) vectors encoding short-hairpin RNAs against rat TRB3 were used to assess the role of TRB3 on hypoxic PH. TRB3 protein expression in PH patients was explored in clinical samples by western blot analysis.
The results of whole-rat genome oligo microarrays showed that the expression of TRB3 and endoplasmic reticulum stress (ERS)-related genes was upregulated in hypoxic PASMCs. TRB3 protein expression was significantly upregulated by hypoxia and thapsigargin. In addition, 4-PBA and 4μ8C, both inhibitors of ERS, decreased the expression of TRB3. TRB3 knockdown promoted apoptosis and damaged the proliferative and migratory abilities of hypoxic PASMCs as well as inhibited activation of the MAPK signaling pathway. TRB3 overexpression stimulated the proliferation and migration of PASMCs but decreased the apoptosis of PASMCs, which was partly reversed by specific inhibitors of ERK, JNK and p38 MAPK. The Co-IP results revealed that TRB3 directly interacts with ERK, JNK, and p38 MAPK. Knockdown of TRB3 in rat lung tissue reduced the right ventricular systolic pressure and decreased pulmonary medial wall thickness in hypoxic PH model rats. Further, the expression of TRB3 in lung tissues was higher in patients with PH compared with those who have normal pulmonary artery pressure.
TRB3 was upregulated in hypoxic PASMCs and was affected by ERS. TRB3 plays a key role in the pathogenesis of hypoxia-induced PH by binding and activating the ERK, JNK, and p38 MAPK pathways. Thus, TRB3 might be a promising target for the treatment of hypoxic PH. |
---|---|
AbstractList | Hypoxic pulmonary hypertension (PH) is a refractory pulmonary vascular remodeling disease, and the efficiency of current PH treatment strategies is unsatisfactory. Tribbles homolog 3 (TRB3), a member of the pseudokinase family, is upregulated in diverse types of cellular stresses and functions as either a pro-proliferative or pro-apoptotic factor depending on the specific microenvironment. The regulatory mechanisms of TRB3 in hypoxic PH are poorly understood.BACKGROUNDHypoxic pulmonary hypertension (PH) is a refractory pulmonary vascular remodeling disease, and the efficiency of current PH treatment strategies is unsatisfactory. Tribbles homolog 3 (TRB3), a member of the pseudokinase family, is upregulated in diverse types of cellular stresses and functions as either a pro-proliferative or pro-apoptotic factor depending on the specific microenvironment. The regulatory mechanisms of TRB3 in hypoxic PH are poorly understood.We performed studies using TRB3-specific silencing and overexpressing lentiviral vectors to investigate the potential roles of TRB3 on hypoxic pulmonary artery smooth muscle cells (PASMCs). Adeno-associated virus type 1(AVV1) vectors encoding short-hairpin RNAs against rat TRB3 were used to assess the role of TRB3 on hypoxic PH. TRB3 protein expression in PH patients was explored in clinical samples by western blot analysis.METHODSWe performed studies using TRB3-specific silencing and overexpressing lentiviral vectors to investigate the potential roles of TRB3 on hypoxic pulmonary artery smooth muscle cells (PASMCs). Adeno-associated virus type 1(AVV1) vectors encoding short-hairpin RNAs against rat TRB3 were used to assess the role of TRB3 on hypoxic PH. TRB3 protein expression in PH patients was explored in clinical samples by western blot analysis.The results of whole-rat genome oligo microarrays showed that the expression of TRB3 and endoplasmic reticulum stress (ERS)-related genes was upregulated in hypoxic PASMCs. TRB3 protein expression was significantly upregulated by hypoxia and thapsigargin. In addition, 4-PBA and 4μ8C, both inhibitors of ERS, decreased the expression of TRB3. TRB3 knockdown promoted apoptosis and damaged the proliferative and migratory abilities of hypoxic PASMCs as well as inhibited activation of the MAPK signaling pathway. TRB3 overexpression stimulated the proliferation and migration of PASMCs but decreased the apoptosis of PASMCs, which was partly reversed by specific inhibitors of ERK, JNK and p38 MAPK. The Co-IP results revealed that TRB3 directly interacts with ERK, JNK, and p38 MAPK. Knockdown of TRB3 in rat lung tissue reduced the right ventricular systolic pressure and decreased pulmonary medial wall thickness in hypoxic PH model rats. Further, the expression of TRB3 in lung tissues was higher in patients with PH compared with those who have normal pulmonary artery pressure.RESULTSThe results of whole-rat genome oligo microarrays showed that the expression of TRB3 and endoplasmic reticulum stress (ERS)-related genes was upregulated in hypoxic PASMCs. TRB3 protein expression was significantly upregulated by hypoxia and thapsigargin. In addition, 4-PBA and 4μ8C, both inhibitors of ERS, decreased the expression of TRB3. TRB3 knockdown promoted apoptosis and damaged the proliferative and migratory abilities of hypoxic PASMCs as well as inhibited activation of the MAPK signaling pathway. TRB3 overexpression stimulated the proliferation and migration of PASMCs but decreased the apoptosis of PASMCs, which was partly reversed by specific inhibitors of ERK, JNK and p38 MAPK. The Co-IP results revealed that TRB3 directly interacts with ERK, JNK, and p38 MAPK. Knockdown of TRB3 in rat lung tissue reduced the right ventricular systolic pressure and decreased pulmonary medial wall thickness in hypoxic PH model rats. Further, the expression of TRB3 in lung tissues was higher in patients with PH compared with those who have normal pulmonary artery pressure.TRB3 was upregulated in hypoxic PASMCs and was affected by ERS. TRB3 plays a key role in the pathogenesis of hypoxia-induced PH by binding and activating the ERK, JNK, and p38 MAPK pathways. Thus, TRB3 might be a promising target for the treatment of hypoxic PH.CONCLUSIONSTRB3 was upregulated in hypoxic PASMCs and was affected by ERS. TRB3 plays a key role in the pathogenesis of hypoxia-induced PH by binding and activating the ERK, JNK, and p38 MAPK pathways. Thus, TRB3 might be a promising target for the treatment of hypoxic PH. Abstract Background Hypoxic pulmonary hypertension (PH) is a refractory pulmonary vascular remodeling disease, and the efficiency of current PH treatment strategies is unsatisfactory. Tribbles homolog 3 (TRB3), a member of the pseudokinase family, is upregulated in diverse types of cellular stresses and functions as either a pro-proliferative or pro-apoptotic factor depending on the specific microenvironment. The regulatory mechanisms of TRB3 in hypoxic PH are poorly understood. Methods We performed studies using TRB3-specific silencing and overexpressing lentiviral vectors to investigate the potential roles of TRB3 on hypoxic pulmonary artery smooth muscle cells (PASMCs). Adeno-associated virus type 1(AVV1) vectors encoding short-hairpin RNAs against rat TRB3 were used to assess the role of TRB3 on hypoxic PH. TRB3 protein expression in PH patients was explored in clinical samples by western blot analysis. Results The results of whole-rat genome oligo microarrays showed that the expression of TRB3 and endoplasmic reticulum stress (ERS)-related genes was upregulated in hypoxic PASMCs. TRB3 protein expression was significantly upregulated by hypoxia and thapsigargin. In addition, 4-PBA and 4μ8C, both inhibitors of ERS, decreased the expression of TRB3. TRB3 knockdown promoted apoptosis and damaged the proliferative and migratory abilities of hypoxic PASMCs as well as inhibited activation of the MAPK signaling pathway. TRB3 overexpression stimulated the proliferation and migration of PASMCs but decreased the apoptosis of PASMCs, which was partly reversed by specific inhibitors of ERK, JNK and p38 MAPK. The Co-IP results revealed that TRB3 directly interacts with ERK, JNK, and p38 MAPK. Knockdown of TRB3 in rat lung tissue reduced the right ventricular systolic pressure and decreased pulmonary medial wall thickness in hypoxic PH model rats. Further, the expression of TRB3 in lung tissues was higher in patients with PH compared with those who have normal pulmonary artery pressure. Conclusions TRB3 was upregulated in hypoxic PASMCs and was affected by ERS. TRB3 plays a key role in the pathogenesis of hypoxia-induced PH by binding and activating the ERK, JNK, and p38 MAPK pathways. Thus, TRB3 might be a promising target for the treatment of hypoxic PH. Hypoxic pulmonary hypertension (PH) is a refractory pulmonary vascular remodeling disease, and the efficiency of current PH treatment strategies is unsatisfactory. Tribbles homolog 3 (TRB3), a member of the pseudokinase family, is upregulated in diverse types of cellular stresses and functions as either a pro-proliferative or pro-apoptotic factor depending on the specific microenvironment. The regulatory mechanisms of TRB3 in hypoxic PH are poorly understood. We performed studies using TRB3-specific silencing and overexpressing lentiviral vectors to investigate the potential roles of TRB3 on hypoxic pulmonary artery smooth muscle cells (PASMCs). Adeno-associated virus type 1(AVV1) vectors encoding short-hairpin RNAs against rat TRB3 were used to assess the role of TRB3 on hypoxic PH. TRB3 protein expression in PH patients was explored in clinical samples by western blot analysis. The results of whole-rat genome oligo microarrays showed that the expression of TRB3 and endoplasmic reticulum stress (ERS)-related genes was upregulated in hypoxic PASMCs. TRB3 protein expression was significantly upregulated by hypoxia and thapsigargin. In addition, 4-PBA and 4μ8C, both inhibitors of ERS, decreased the expression of TRB3. TRB3 knockdown promoted apoptosis and damaged the proliferative and migratory abilities of hypoxic PASMCs as well as inhibited activation of the MAPK signaling pathway. TRB3 overexpression stimulated the proliferation and migration of PASMCs but decreased the apoptosis of PASMCs, which was partly reversed by specific inhibitors of ERK, JNK and p38 MAPK. The Co-IP results revealed that TRB3 directly interacts with ERK, JNK, and p38 MAPK. Knockdown of TRB3 in rat lung tissue reduced the right ventricular systolic pressure and decreased pulmonary medial wall thickness in hypoxic PH model rats. Further, the expression of TRB3 in lung tissues was higher in patients with PH compared with those who have normal pulmonary artery pressure. TRB3 was upregulated in hypoxic PASMCs and was affected by ERS. TRB3 plays a key role in the pathogenesis of hypoxia-induced PH by binding and activating the ERK, JNK, and p38 MAPK pathways. Thus, TRB3 might be a promising target for the treatment of hypoxic PH. Background Hypoxic pulmonary hypertension (PH) is a refractory pulmonary vascular remodeling disease, and the efficiency of current PH treatment strategies is unsatisfactory. Tribbles homolog 3 (TRB3), a member of the pseudokinase family, is upregulated in diverse types of cellular stresses and functions as either a pro-proliferative or pro-apoptotic factor depending on the specific microenvironment. The regulatory mechanisms of TRB3 in hypoxic PH are poorly understood. Methods We performed studies using TRB3-specific silencing and overexpressing lentiviral vectors to investigate the potential roles of TRB3 on hypoxic pulmonary artery smooth muscle cells (PASMCs). Adeno-associated virus type 1(AVV1) vectors encoding short-hairpin RNAs against rat TRB3 were used to assess the role of TRB3 on hypoxic PH. TRB3 protein expression in PH patients was explored in clinical samples by western blot analysis. Results The results of whole-rat genome oligo microarrays showed that the expression of TRB3 and endoplasmic reticulum stress (ERS)-related genes was upregulated in hypoxic PASMCs. TRB3 protein expression was significantly upregulated by hypoxia and thapsigargin. In addition, 4-PBA and 4μ8C, both inhibitors of ERS, decreased the expression of TRB3. TRB3 knockdown promoted apoptosis and damaged the proliferative and migratory abilities of hypoxic PASMCs as well as inhibited activation of the MAPK signaling pathway. TRB3 overexpression stimulated the proliferation and migration of PASMCs but decreased the apoptosis of PASMCs, which was partly reversed by specific inhibitors of ERK, JNK and p38 MAPK. The Co-IP results revealed that TRB3 directly interacts with ERK, JNK, and p38 MAPK. Knockdown of TRB3 in rat lung tissue reduced the right ventricular systolic pressure and decreased pulmonary medial wall thickness in hypoxic PH model rats. Further, the expression of TRB3 in lung tissues was higher in patients with PH compared with those who have normal pulmonary artery pressure. Conclusions TRB3 was upregulated in hypoxic PASMCs and was affected by ERS. TRB3 plays a key role in the pathogenesis of hypoxia-induced PH by binding and activating the ERK, JNK, and p38 MAPK pathways. Thus, TRB3 might be a promising target for the treatment of hypoxic PH. Hypoxic pulmonary hypertension (PH) is a refractory pulmonary vascular remodeling disease, and the efficiency of current PH treatment strategies is unsatisfactory. Tribbles homolog 3 (TRB3), a member of the pseudokinase family, is upregulated in diverse types of cellular stresses and functions as either a pro-proliferative or pro-apoptotic factor depending on the specific microenvironment. The regulatory mechanisms of TRB3 in hypoxic PH are poorly understood. We performed studies using TRB3-specific silencing and overexpressing lentiviral vectors to investigate the potential roles of TRB3 on hypoxic pulmonary artery smooth muscle cells (PASMCs). Adeno-associated virus type 1(AVV1) vectors encoding short-hairpin RNAs against rat TRB3 were used to assess the role of TRB3 on hypoxic PH. TRB3 protein expression in PH patients was explored in clinical samples by western blot analysis. The results of whole-rat genome oligo microarrays showed that the expression of TRB3 and endoplasmic reticulum stress (ERS)-related genes was upregulated in hypoxic PASMCs. TRB3 protein expression was significantly upregulated by hypoxia and thapsigargin. In addition, 4-PBA and 4[mu]8C, both inhibitors of ERS, decreased the expression of TRB3. TRB3 knockdown promoted apoptosis and damaged the proliferative and migratory abilities of hypoxic PASMCs as well as inhibited activation of the MAPK signaling pathway. TRB3 overexpression stimulated the proliferation and migration of PASMCs but decreased the apoptosis of PASMCs, which was partly reversed by specific inhibitors of ERK, JNK and p38 MAPK. The Co-IP results revealed that TRB3 directly interacts with ERK, JNK, and p38 MAPK. Knockdown of TRB3 in rat lung tissue reduced the right ventricular systolic pressure and decreased pulmonary medial wall thickness in hypoxic PH model rats. Further, the expression of TRB3 in lung tissues was higher in patients with PH compared with those who have normal pulmonary artery pressure. TRB3 was upregulated in hypoxic PASMCs and was affected by ERS. TRB3 plays a key role in the pathogenesis of hypoxia-induced PH by binding and activating the ERK, JNK, and p38 MAPK pathways. Thus, TRB3 might be a promising target for the treatment of hypoxic PH. Background Hypoxic pulmonary hypertension (PH) is a refractory pulmonary vascular remodeling disease, and the efficiency of current PH treatment strategies is unsatisfactory. Tribbles homolog 3 (TRB3), a member of the pseudokinase family, is upregulated in diverse types of cellular stresses and functions as either a pro-proliferative or pro-apoptotic factor depending on the specific microenvironment. The regulatory mechanisms of TRB3 in hypoxic PH are poorly understood. Methods We performed studies using TRB3-specific silencing and overexpressing lentiviral vectors to investigate the potential roles of TRB3 on hypoxic pulmonary artery smooth muscle cells (PASMCs). Adeno-associated virus type 1(AVV1) vectors encoding short-hairpin RNAs against rat TRB3 were used to assess the role of TRB3 on hypoxic PH. TRB3 protein expression in PH patients was explored in clinical samples by western blot analysis. Results The results of whole-rat genome oligo microarrays showed that the expression of TRB3 and endoplasmic reticulum stress (ERS)-related genes was upregulated in hypoxic PASMCs. TRB3 protein expression was significantly upregulated by hypoxia and thapsigargin. In addition, 4-PBA and 4[mu]8C, both inhibitors of ERS, decreased the expression of TRB3. TRB3 knockdown promoted apoptosis and damaged the proliferative and migratory abilities of hypoxic PASMCs as well as inhibited activation of the MAPK signaling pathway. TRB3 overexpression stimulated the proliferation and migration of PASMCs but decreased the apoptosis of PASMCs, which was partly reversed by specific inhibitors of ERK, JNK and p38 MAPK. The Co-IP results revealed that TRB3 directly interacts with ERK, JNK, and p38 MAPK. Knockdown of TRB3 in rat lung tissue reduced the right ventricular systolic pressure and decreased pulmonary medial wall thickness in hypoxic PH model rats. Further, the expression of TRB3 in lung tissues was higher in patients with PH compared with those who have normal pulmonary artery pressure. Conclusions TRB3 was upregulated in hypoxic PASMCs and was affected by ERS. TRB3 plays a key role in the pathogenesis of hypoxia-induced PH by binding and activating the ERK, JNK, and p38 MAPK pathways. Thus, TRB3 might be a promising target for the treatment of hypoxic PH. Keywords: PH, Hypoxia, PASMCs, TRB3, MAPK |
ArticleNumber | 312 |
Audience | Academic |
Author | Li, Xiaochen Xie, Min Cao, Xiaopei He, Yuanzhou Liu, Xiansheng Fang, Xiaoyu Guo, Mingzhou Xu, Yongjian |
Author_xml | – sequence: 1 givenname: Xiaopei surname: Cao fullname: Cao, Xiaopei – sequence: 2 givenname: Xiaoyu surname: Fang fullname: Fang, Xiaoyu – sequence: 3 givenname: Mingzhou surname: Guo fullname: Guo, Mingzhou – sequence: 4 givenname: Xiaochen surname: Li fullname: Li, Xiaochen – sequence: 5 givenname: Yuanzhou surname: He fullname: He, Yuanzhou – sequence: 6 givenname: Min surname: Xie fullname: Xie, Min – sequence: 7 givenname: Yongjian surname: Xu fullname: Xu, Yongjian – sequence: 8 givenname: Xiansheng surname: Liu fullname: Liu, Xiansheng |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/34906150$$D View this record in MEDLINE/PubMed |
BookMark | eNp9Ul1vFCEUnZga-6F_wAcziS--TIUBBubFZG38aKzRmJr4RljmsstmBrbArO6_l9lttdsYQwhwOedc7uWcFkfOOyiK5xidYyya1xHXLcEVqvPELRIVfVScYNqwqm3Jj6N7--PiNMYVQpgLzp4Ux4S2qMEMnRT99be3pBygsypBLDcq6rFXoQww-A566xblfFsqnexGpemUllB-nn39VEa7cGoHWKu0_Km2pXXlcrv2v6wu12M_eKfCdopASOCi9e5p8dioPsKz2_Ws-P7-3fXFx-rqy4fLi9lVpVlDUmVAGEzMXHPaAOsUb2qjEe_UvMMEMNS4qzk0LWHARYsbTKkwjCnDtRCEGnJWXO51O69Wch3skF8ivbJyF_BhIVVIVvcgdcfqRnRECMNpR5kAQjBHpGWt0AZPWm_2WutxntukwaWg-gPRwxtnl3LhN1I0HOX_yQKvbgWCvxkhJjnYqKHvlQM_Rlk3GFGMCBUZ-vIBdOXHkLu8Q-G6bjllf1ELlQuwzvicV0-icjY1hQnGprTn_0Dl0cFgdTaSsTl-QHhxv9A_Fd55JQPEHqCDjzGAkdqmbAo_1W17iZGcbCn3tpTZlnJnS0kztX5AvVP_D-k3M8LkQw |
CitedBy_id | crossref_primary_10_1016_j_heliyon_2023_e22922 crossref_primary_10_1007_s11010_024_05173_z crossref_primary_10_1007_s11626_024_00947_7 crossref_primary_10_1016_j_intimp_2023_110599 crossref_primary_10_1186_s12964_025_02159_2 crossref_primary_10_4196_kjpp_2024_28_1_39 crossref_primary_10_1016_j_ejphar_2023_176077 crossref_primary_10_3389_fgene_2022_916281 crossref_primary_10_1016_j_ydbio_2024_01_011 crossref_primary_10_3892_ijmm_2025_5485 crossref_primary_10_1007_s00424_023_02854_4 crossref_primary_10_1016_j_taap_2023_116596 crossref_primary_10_3390_biomedicines11123109 crossref_primary_10_3390_ijms241210206 crossref_primary_10_1089_ten_tea_2023_0362 crossref_primary_10_1111_1440_1681_13843 |
Cites_doi | 10.1152/ajplung.00189.2015 10.1159/000374015 10.1038/sj.onc.1206367 10.1038/nrm3270 10.1038/sj.cr.7290105 10.1242/jcs.082875 10.1038/ncomms8951 10.1038/emboj.2009.370 10.1210/er.2011-1042 10.1007/s00018-008-8255-3 10.7150/ijbs.29737 10.1016/j.yexcr.2007.07.017 10.1038/sj.emboj.7600596 10.1161/CIRCULATIONAHA.112.133413 10.1016/j.cellsig.2006.06.010 10.1128/MCB.00218-07 10.1152/ajplung.00281.2009 10.1016/j.jacc.2009.04.018 10.1016/j.metabol.2014.03.003 10.1172/JCI37948 10.1146/annurev-med-041717-085955 10.1073/pnas.1214014110 10.1161/CIRCULATIONAHA.113.001585 10.2174/1389203718666170406124547 10.1016/j.yexcr.2015.10.013 10.1074/jbc.M407732200 10.1152/ajplung.00012.2004 10.1126/science.1123374 10.1002/jcp.26279 |
ContentType | Journal Article |
Copyright | 2021. The Author(s). COPYRIGHT 2021 BioMed Central Ltd. 2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. The Author(s) 2021 |
Copyright_xml | – notice: 2021. The Author(s). – notice: COPYRIGHT 2021 BioMed Central Ltd. – notice: 2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: The Author(s) 2021 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7QL 7U7 7U9 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AEUYN AFKRA AZQEC BENPR C1K CCPQU DWQXO FYUFA GHDGH H94 K9. M0S M1P M7N PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI 7X8 5PM DOA |
DOI | 10.1186/s12931-021-01908-4 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Bacteriology Abstracts (Microbiology B) Toxicology Abstracts Virology and AIDS Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni Edition) ProQuest One Sustainability ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central Environmental Sciences and Pollution Management ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Health & Medical Collection (Alumni Edition) Medical Database Algology Mycology and Protozoology Abstracts (Microbiology C) ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing Environmental Sciences and Pollution Management ProQuest Central ProQuest One Sustainability ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Bacteriology Abstracts (Microbiology B) Algology Mycology and Protozoology Abstracts (Microbiology C) Health & Medical Research Collection AIDS and Cancer Research Abstracts ProQuest Central (New) ProQuest Medical Library (Alumni) Virology and AIDS Abstracts Toxicology Abstracts ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE Publicly Available Content Database |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1465-993X |
EndPage | 15 |
ExternalDocumentID | oai_doaj_org_article_cd5268d388f74d458e3317039598cf1f PMC8670293 A693558553 34906150 10_1186_s12931_021_01908_4 |
Genre | Journal Article |
GeographicLocations | China United States--US Japan |
GeographicLocations_xml | – name: China – name: United States--US – name: Japan |
GrantInformation_xml | – fundername: national natural science foundation of china grantid: No. 81670048 – fundername: national key research and development programs of china grantid: No.2016YFC1304500 – fundername: ; grantid: No.2016YFC1304500 – fundername: ; grantid: No. 81670048 |
GroupedDBID | --- 0R~ 29P 2WC 4.4 53G 5VS 7X7 88E 8FI 8FJ AAFWJ AAJSJ AASML AAWTL AAYXX ABDBF ABUWG ACGFO ACGFS ACIHN ACPRK ACUHS ADBBV ADRAZ ADUKV AEAQA AENEX AEUYN AFKRA AFPKN AFRAH AHBYD AHMBA AHYZX ALIPV ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS BAPOH BAWUL BCNDV BENPR BFQNJ BMC BPHCQ BVXVI C6C CCPQU CITATION CS3 DIK DU5 E3Z EAD EAP EAS EBD EBLON EBS EMB EMK EMOBN ESX F5P FYUFA GROUPED_DOAJ GX1 HMCUK HYE IAO IHR INH INR ITC KQ8 M1P M48 O5R O5S OK1 OVT P2P PGMZT PHGZM PHGZT PIMPY PQQKQ PROAC PSQYO RBZ RNS ROL RPM RSV SMD SOJ SV3 TR2 TUS UKHRP W2D WOQ WOW XSB CGR CUY CVF ECM EIF NPM PJZUB PPXIY PMFND 3V. 7QL 7U7 7U9 7XB 8FK AZQEC C1K DWQXO H94 K9. M7N PKEHL PQEST PQUKI 7X8 5PM PUEGO |
ID | FETCH-LOGICAL-c563t-fe8f13fbc746e5da762fc07dabd13e1e21d27e6935e789161448f55af7c8834f3 |
IEDL.DBID | M48 |
ISSN | 1465-993X 1465-9921 |
IngestDate | Wed Aug 27 01:32:23 EDT 2025 Thu Aug 21 14:05:18 EDT 2025 Tue Aug 05 10:58:37 EDT 2025 Sat Aug 23 14:58:18 EDT 2025 Tue Jun 17 21:30:37 EDT 2025 Tue Jun 10 20:39:42 EDT 2025 Mon Jul 21 06:08:13 EDT 2025 Tue Jul 01 02:43:23 EDT 2025 Thu Apr 24 22:52:51 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | PH TRB3 Hypoxia MAPK PASMCs |
Language | English |
License | 2021. The Author(s). Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c563t-fe8f13fbc746e5da762fc07dabd13e1e21d27e6935e789161448f55af7c8834f3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
OpenAccessLink | https://www.proquest.com/docview/2611229745?pq-origsite=%requestingapplication% |
PMID | 34906150 |
PQID | 2611229745 |
PQPubID | 42864 |
PageCount | 15 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_cd5268d388f74d458e3317039598cf1f pubmedcentral_primary_oai_pubmedcentral_nih_gov_8670293 proquest_miscellaneous_2610410348 proquest_journals_2611229745 gale_infotracmisc_A693558553 gale_infotracacademiconefile_A693558553 pubmed_primary_34906150 crossref_citationtrail_10_1186_s12931_021_01908_4 crossref_primary_10_1186_s12931_021_01908_4 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2021-12-14 |
PublicationDateYYYYMMDD | 2021-12-14 |
PublicationDate_xml | – month: 12 year: 2021 text: 2021-12-14 day: 14 |
PublicationDecade | 2020 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: London |
PublicationTitle | Respiratory research |
PublicationTitleAlternate | Respir Res |
PublicationYear | 2021 |
Publisher | BioMed Central Ltd BioMed Central BMC |
Publisher_xml | – name: BioMed Central Ltd – name: BioMed Central – name: BMC |
References | T Tajsic (1908_CR2) 2011; 1 T Ord (1908_CR9) 2017; 18 X Cao (1908_CR5) 2019; 11 M Tang (1908_CR19) 2008; 65 Y Liu (1908_CR30) 2018; 233 B Hong (1908_CR21) 2019; 15 F Hua (1908_CR33) 2011; 124 X Li (1908_CR16) 2016; 310 E Kiss-Toth (1908_CR18) 2004; 279 L Qi (1908_CR28) 2006; 312 D Sun (1908_CR22) 2018; 10 L Hadri (1908_CR23) 2013; 128 D Ord (1908_CR11) 2007; 313 KK Sheares (1908_CR31) 2004; 287 N Fang (1908_CR10) 2014; 63 F Hua (1908_CR24) 2015; 6 L Wei (1908_CR15) 2010; 298 C Hetz (1908_CR4) 2012; 13 M Salazar (1908_CR25) 2009; 119 N Ohoka (1908_CR7) 2005; 24 W Yu (1908_CR29) 2019; 12 MC Chan (1908_CR26) 2007; 27 S Prudente (1908_CR13) 2012; 33 W Zhang (1908_CR17) 2002; 12 Z Hegedus (1908_CR32) 2007; 19 Y He (1908_CR12) 2015; 339 E Spiekerkoetter (1908_CR1) 2018; 70 P Dromparis (1908_CR6) 2013; 127 AJ Bowers (1908_CR8) 2003; 22 J Izrailit (1908_CR20) 2013; 110 NW Morrell (1908_CR3) 2009; 54 MC Chan (1908_CR27) 2010; 29 X Yu (1908_CR14) 2015; 35 |
References_xml | – volume: 310 start-page: L299 year: 2016 ident: 1908_CR16 publication-title: Am J Physiol Lung Cell Mol Physiol doi: 10.1152/ajplung.00189.2015 – volume: 35 start-page: 2079 year: 2015 ident: 1908_CR14 publication-title: Cell Physiol Biochem doi: 10.1159/000374015 – volume: 22 start-page: 2823 year: 2003 ident: 1908_CR8 publication-title: Oncogene doi: 10.1038/sj.onc.1206367 – volume: 13 start-page: 89 year: 2012 ident: 1908_CR4 publication-title: Nat Rev Mol Cell Biol doi: 10.1038/nrm3270 – volume: 12 start-page: 9 year: 2002 ident: 1908_CR17 publication-title: Cell Res doi: 10.1038/sj.cr.7290105 – volume: 12 start-page: 3247 year: 2019 ident: 1908_CR29 publication-title: Int J Clin Exp Pathol – volume: 124 start-page: 3235 year: 2011 ident: 1908_CR33 publication-title: J Cell Sci doi: 10.1242/jcs.082875 – volume: 6 start-page: 7951 year: 2015 ident: 1908_CR24 publication-title: Nat Commun doi: 10.1038/ncomms8951 – volume: 29 start-page: 559 year: 2010 ident: 1908_CR27 publication-title: EMBO J doi: 10.1038/emboj.2009.370 – volume: 33 start-page: 526 year: 2012 ident: 1908_CR13 publication-title: Endocr Rev doi: 10.1210/er.2011-1042 – volume: 65 start-page: 2924 year: 2008 ident: 1908_CR19 publication-title: Cell Mol Life Sci doi: 10.1007/s00018-008-8255-3 – volume: 15 start-page: 587 year: 2019 ident: 1908_CR21 publication-title: Int J Biol Sci doi: 10.7150/ijbs.29737 – volume: 313 start-page: 3556 year: 2007 ident: 1908_CR11 publication-title: Exp Cell Res doi: 10.1016/j.yexcr.2007.07.017 – volume: 11 start-page: 641 year: 2019 ident: 1908_CR5 publication-title: Am J Transl Res – volume: 24 start-page: 1243 year: 2005 ident: 1908_CR7 publication-title: EMBO J doi: 10.1038/sj.emboj.7600596 – volume: 10 start-page: 581 year: 2018 ident: 1908_CR22 publication-title: Am J Transl Res – volume: 127 start-page: 115 year: 2013 ident: 1908_CR6 publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.112.133413 – volume: 19 start-page: 238 year: 2007 ident: 1908_CR32 publication-title: Cell Signal doi: 10.1016/j.cellsig.2006.06.010 – volume: 27 start-page: 5776 year: 2007 ident: 1908_CR26 publication-title: Mol Cell Biol doi: 10.1128/MCB.00218-07 – volume: 298 start-page: L863 year: 2010 ident: 1908_CR15 publication-title: Am J Physiol Lung Cell Mol Physiol doi: 10.1152/ajplung.00281.2009 – volume: 54 start-page: S20 year: 2009 ident: 1908_CR3 publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2009.04.018 – volume: 63 start-page: 822 year: 2014 ident: 1908_CR10 publication-title: Metabolism doi: 10.1016/j.metabol.2014.03.003 – volume: 119 start-page: 1359 year: 2009 ident: 1908_CR25 publication-title: J Clin Invest doi: 10.1172/JCI37948 – volume: 70 start-page: 45 year: 2018 ident: 1908_CR1 publication-title: Annu Rev Med doi: 10.1146/annurev-med-041717-085955 – volume: 1 start-page: 295 year: 2011 ident: 1908_CR2 publication-title: Compr Physiol – volume: 110 start-page: 1714 year: 2013 ident: 1908_CR20 publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.1214014110 – volume: 128 start-page: 512 year: 2013 ident: 1908_CR23 publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.113.001585 – volume: 18 start-page: 819 year: 2017 ident: 1908_CR9 publication-title: Curr Protein Pept Sci doi: 10.2174/1389203718666170406124547 – volume: 339 start-page: 122 year: 2015 ident: 1908_CR12 publication-title: Exp Cell Res doi: 10.1016/j.yexcr.2015.10.013 – volume: 279 start-page: 42703 year: 2004 ident: 1908_CR18 publication-title: J Biol Chem doi: 10.1074/jbc.M407732200 – volume: 287 start-page: L919 year: 2004 ident: 1908_CR31 publication-title: Am J Physiol Lung Cell Mol Physiol doi: 10.1152/ajplung.00012.2004 – volume: 312 start-page: 1763 year: 2006 ident: 1908_CR28 publication-title: Science doi: 10.1126/science.1123374 – volume: 233 start-page: 4801 year: 2018 ident: 1908_CR30 publication-title: J Cell Physiol doi: 10.1002/jcp.26279 |
SSID | ssj0017875 |
Score | 2.4306283 |
Snippet | Hypoxic pulmonary hypertension (PH) is a refractory pulmonary vascular remodeling disease, and the efficiency of current PH treatment strategies is... Background Hypoxic pulmonary hypertension (PH) is a refractory pulmonary vascular remodeling disease, and the efficiency of current PH treatment strategies is... Abstract Background Hypoxic pulmonary hypertension (PH) is a refractory pulmonary vascular remodeling disease, and the efficiency of current PH treatment... |
SourceID | doaj pubmedcentral proquest gale pubmed crossref |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 312 |
SubjectTerms | Animals Antibodies Apoptosis Biotechnology Blood pressure Care and treatment Cell Communication Cell culture Cellular stress response Development and progression Diagnosis Disease Models, Animal Endoplasmic reticulum Endoplasmic Reticulum Stress - genetics Flow cytometry Gene Expression Regulation Genomes Health aspects Health services Heart Homology Hypertension Hypertension, Pulmonary - etiology Hypertension, Pulmonary - genetics Hypertension, Pulmonary - metabolism Hypoxia Hypoxia - complications Hypoxia - genetics Hypoxia - metabolism Laboratory animals Lung diseases Lungs Male MAP kinase MAP Kinase Signaling System - genetics MAPK Microenvironments Mitogen-activated protein kinases Muscles PASMCs Pathogenesis Patients Protein Serine-Threonine Kinases - antagonists & inhibitors Protein Serine-Threonine Kinases - biosynthesis Protein Serine-Threonine Kinases - genetics Proteins Pulmonary arteries Pulmonary artery Pulmonary Artery - pathology Pulmonary Artery - physiopathology Pulmonary hypertension Rats Rats, Sprague-Dawley Regulatory mechanisms (biology) Signal Transduction Signaling Smooth muscle Systolic pressure Thapsigargin TRB3 Up-Regulation Vascular Remodeling - genetics Ventricle |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Li9RAEG5kD-JFfBtdpQXBg4RNvzvHWXFZlBGRXdhbk_SDHRgyw-wMOv_eqk4yTBD04jHpCqS7qvqrSqq_IuR9kyrZ8sqUqRKylCzGsraVLCOgSxQRIC7X5sy_6ctr-eVG3Ry1-sKasJ4euF-4Mx-QkCQIa5ORQSobBUBeJWpVW59Ywt0XMG9Mpob_B2CGajwiY_XZHaIapM0cU-e6sqWcwFBm6_9zTz4CpWnB5BECXTwiD4fQkc76V35M7sXuCbk_H36OPyXLqx_nguajIBA_0rHGlG5ibncDGEXbPcWDDPgZFq4g9qPz2fevFIs4miyADYp_Nnu66Ojtfr36tfB0vVuCqTabPd6Jm1zxvuqekeuLz1efLsuhmULplRbbMkWbmEitN1JHFRrYBJOvTGjawERkkbPATdS1UNFYiBkh0bJJqSYZb62QSTwnJ92qiy8JbSCkUKDMhgcmE3YN1Tpxo1WA4IKnUBA2rq3zA9M4NrxYupxxWO16fTjQh8v6cLIgHw_PrHuejb9Kn6PKDpLIkZ1vgOW4wXLcvyynIB9Q4Q49GV7PN8OBBJgkcmK5mc7c80qJgpxOJMED_XR4NBk37AB3DjJTxjlka6og7w7D-CRWtXVxtcsylWTgJLYgL3oLO0xJyDqT9RfETGxvMufpSLe4zfzgVpsKVuzV_1ik1-QBR7dhvGTylJxsN7v4BsKwbfs2e9xvnoYsaQ priority: 102 providerName: Directory of Open Access Journals – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1bi9QwFA66gvgi3re6SgTBBwnb3NMnmRWXRRkR2YV5C500cQeGdpwLOv_eczKdcYuwj21Oocm5fUnOhZB3dSrVVJSWpVIqpniMrHKlYhG8S5QRXFyOzRl_MxdX6stET_oDt1UfVrm3idlQN13AM_JTQPpcCEC_-uPiF8OuUXi72rfQuEvuYekyDOmyk8OGi4Mw6l12kWZVJfg-acaZ0xX6OdhIC9xMV6VjauCYcv3-_630DTc1DKG84ZPOH5GHPZikox33H5M7sX1C7o_76_KnZH7540zSnBwCiJLuo07pMuYGOOC16HRLMbUBD2bhCdAgHY--f6UY1lFnAmxZ_Lve0llLr7eL7s8s0MVmDqtRL7f4Ji5zDHzXPiNX558vP12wvr0CC9rINUvRJS7TNFhlom5qMIsplLappw2XkUfBG2GjqaSO1gGKhK2XS1rXyQbnpEryOTlquzYeE1oDyNDA3lo0XCXsI2pMEtboBuCGSE1B-H5tfehrj2MLjLnPexBn_I4fHvjhMz-8KsiHwzeLXeWNW6nPkGUHSqyanV90y5--V0IfGixu00jnklWN0i5KgE-lrHTlQuKpIO-R4R51G34v1H2KAkwSq2T5kcnV6LWWBTkZUIJOhuHwXmR8bxNW_p8EF-TtYRi_xDi3NnabTFMqDmrjCvJiJ2GHKUlV5fL9BbED2RvMeTjSzq5zxXBnbAkr9vL233pFHghUCC4YVyfkaL3cxNcAudbTN1mv_gKl1yaX priority: 102 providerName: ProQuest |
Title | TRB3 mediates vascular remodeling by activating the MAPK signaling pathway in hypoxic pulmonary hypertension |
URI | https://www.ncbi.nlm.nih.gov/pubmed/34906150 https://www.proquest.com/docview/2611229745 https://www.proquest.com/docview/2610410348 https://pubmed.ncbi.nlm.nih.gov/PMC8670293 https://doaj.org/article/cd5268d388f74d458e3317039598cf1f |
Volume | 22 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3da9swED_6AWMvY9_z1gUNBnsY3qwvS34YIxktJSOldA3kTTi21AaCk7kJa_77nRQ7q1kZ7MnYOhtLd-e7k-9-B_A-d4mYskTFLuEiFtTaONOJiC1aF8stmriQmzM6S0_HYjiRkz1o2x01C3hzb2jn-0mN6_mn25-br6jwX4LC6_TzjbdZGBQzHxhniY7FPhyiZVJeUUfiz18FFE65rTaSMdrlSVtEc-8zOoYq4Pn__dW-Y7a6KZV3bNTJY3jUOJekv5WGJ7Bnq6fwYNT8Pn8G88uLASehWAQ9TNJmoZLahoY4aMXIdEN8qYPfqMUz9A7JqH_-nfg0jzwQ-BbGv_INmVXkerNc3M4KslzPUZjzeuOv2DrkxC-q5zA-Ob78dho37RbiQqZ8FTurHeVuWiiRWlnm-Jl0RaLKfFpSbqlltGTKphmXVmn0KjEU007K3KlCay4cfwEH1aKyr4Dk6HRIZHfOSiqc7yuapo6pVJbofjBXRkDbtTVFg0XuW2LMTYhJdGq2_DDIDxP4YUQEH3f3LLdIHP-kHniW7Sg9ina4sKivTKOUpig92E3JtXZKlEJqy9GdSngmM1046iL44BluvPTh6xV5U7KAk_SoWaafBnR6KXkERx1K1NGiO9yKjGlF3GDsShnDeE5G8G437O_0eW-VXawDTSIoqpGO4OVWwnZT4iILcP4RqI7sdebcHalm1wFBXKcqwRV7_V9L-gYeMq8flMVUHMHBql7bt-iRraY92FcT1YPDfn_4Y4jHwfHZ-UUv7G_0ggr-BnIsMrE |
linkProvider | Scholars Portal |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bb9MwFD4anQS8IO4EBhgJxAOKFt8S5wGhFjZ1dK2maZP2ZtLEZpWqpPSi0T_Fb-TYTcoipL3tMbETxT6378TnAvA-s5EYsygJbcRFKKgxYaoiERq0LoYbNHE-Nmc4ivvn4vuFvNiBP00ujAurbHSiV9RFlbt_5PuI9CljiH7ll9mv0HWNcqerTQuNDVsMzPoKXbbF56NvSN8PjB0enH3th3VXgTCXMV-G1ihLuR3niYiNLDLUBjaPkiIbF5QbahgtWGLilEuTKARP6HEoK2Vmk1wpLizH996BXcHRlenAbu9gdHK6PbdA9pebfCYZpimjTZqOivcXzrKi686c-55GKhQtU-g7BvxvF64ZxnbQ5jUrePgQHtTwlXQ3_PYIdkz5GO4O6wP6JzA9O-1x4tNREMOSJs6VzI1vuYN2kozXxCVTuF_BeIX4kwy7JwPiAkkyP8E1Sb7K1mRSksv1rPo9yclsNcX9z-Zrd8fMfdR9VT6F81vZ-mfQKavSvACSIayRyFAZK6iwrnNpHFuWxLJAgMNsEQBt9lbndbVz13Rjqr3Xo2K9oYdGemhPDy0C-LR9Zrap9XHj7J4j2Xamq9Ptb1Tzn7oWe50XrpxOwZWyiSiEVIYjYIt4KlOVW2oD-OgIrp02wc_LszopAhfp6nLpbuzr30vJA9hrzUQtkLeHG5bRtRZa6H8yE8C77bB70kXWlaZa-TmRoCioKoDnGw7bLomL1DcMCCBp8V5rze2RcnLpa5SrOIlwx17e_Flv4V7_bHisj49Gg1dwnznhoCykYg86y_nKvEbAtxy_qaWMwI_bFuy_7pxlNg |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=TRB3+mediates+vascular+remodeling+by+activating+the+MAPK+signaling+pathway+in+hypoxic+pulmonary+hypertension&rft.jtitle=Respiratory+research&rft.au=Cao%2C+Xiaopei&rft.au=Fang%2C+Xiaoyu&rft.au=Guo%2C+Mingzhou&rft.au=Li%2C+Xiaochen&rft.date=2021-12-14&rft.issn=1465-993X&rft.eissn=1465-993X&rft.volume=22&rft.issue=1&rft_id=info:doi/10.1186%2Fs12931-021-01908-4&rft.externalDBID=n%2Fa&rft.externalDocID=10_1186_s12931_021_01908_4 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1465-993X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1465-993X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1465-993X&client=summon |